98%
921
2 minutes
20
Older adults with established cardiovascular diseases (CVD) are at elevated risk of heart failure (HF). Frailty, a hallmark of multi-system aging, may contribute to HF development through inflammation. However, population-based evidence remains scarce. Leveraging data from 49,530 CVD patients in the UK Biobank, frailty was measured by five components: weight loss, exhaustion, low physical activity, slow walking speed, and low grip strength. We employed Cox regression models to assess the association between frailty and incident HF, and conducted mediation analyses to evaluate mediating roles of 15 inflammatory markers in this association. Furthermore, we constructed a polygenic risk score (PRS) for HF risk based on the Global Biobank Meta-analysis Initiative (N = 1,020,441), and evaluated the joint association and interaction between frailty and PRS in relation to incident HF. During a median follow-up of 13.3 years, 6293 participants developed HF. Compared to robust individuals, pre-frail (hazard ratio (HR) = 1.31 [95% CI: 1.23-1.40]) or frail (HR = 1.80 [1.64-1.98]) participants had a higher risk of HF, and the potential causality was suggested by Mendelian randomization. Such relationship was partially mediated by inflammatory markers, including interleukin-6, tumor necrosis factor-α, and C-reactive protein. Moreover, individuals with both frailty and high PRS had the greatest risk of HF (HR = 4.35 [3.74-5.06]), with a relative excess risk due to interaction of 1.39, accounting for 32% of total risk. Frailty interacts with PRS to enhance risk stratification of HF. Inflammation may mediate the frailty-HF association, suggesting the potential of anti-inflammatory interventions to mitigate HF risk in frail CVD patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11357-025-01734-2 | DOI Listing |
J Med Microbiol
September 2025
Alberta Precision Laboratories Public Health Lab, Edmonton, Alberta, Canada.
For thousands of years, parasitic infections have represented a constant challenge to human health. Despite constant progress in science and medicine, the challenge has remained mostly unchanged over the years, partly due to the vast complexity of the host-parasite-environment relationships. Over the last century, our approaches to these challenges have evolved through considerable advances in science and technology, offering new and better solutions.
View Article and Find Full Text PDFCurr Med Res Opin
September 2025
Department of Internal Medicine, Taksim Training and Research Hospital, Istanbul, Turkey.
Introduction: Diabetes Mellitus is a chronic disease characterised by elevated plasma glucose (PG) levels. HbA1c has been widely utilized for diabetes diagnosis. However, certain conditions restrict its use.
View Article and Find Full Text PDFWorld J Pediatr Congenit Heart Surg
September 2025
Postgraduate Program in Health Sciences, Medical School, Federal University of Amazonas (UFAM), Manaus, Amazonas, Brazil.
To analyze in-hospital mortality in children undergoing congenital heart interventions in the only public referral center in Amazonas, North Brazil, between 2014 and 2022. This retrospective cohort study included 1041 patients undergoing cardiac interventions for congenital heart disease, of whom 135 died during hospitalization. Records were reviewed to obtain demographic, clinical, and surgical data.
View Article and Find Full Text PDFJ Med Screen
September 2025
Institute of Cardiovascular Science, University College London, London, UK.
It is claimed that polygenic risk scores will transform disease prevention, but a typical polygenic risk score for a common disease only detects 11% of affected individuals at a 5% false positive rate. This level of screening performance is not useful. Claims to the contrary are either due to incorrect interpretation of the data or other influences.
View Article and Find Full Text PDFJAMA Cardiol
September 2025
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.